Eli Lilly

August 5, 2025

Trump Threatens 250% Tariffs on Drug Imports

Tariff escalation targets overseas pharmaceutical production President Donald Trump announced Tuesday that the U.S. may impose tariffs as high as 250% on pharmaceutical imports within the next 18 months. Speaking on CNBC’s

May 6, 2025

Wall Street Declines Amid Tariff Uncertainty

Wall Street’s main indexes declined on Tuesday as investors faced uncertainty surrounding U.S. President Donald Trump’s tariffs and awaited the Federal Reserve’s interest rate decision. Trump’s announcement of new pharma tariffs set

March 21, 2025

Johnson & Johnson Boosts U.S. Investments to $55B

Expansion Amid Tariff Threats Johnson & Johnson (JNJ.N) announced plans to increase its U.S. investments by 25% to more than $55 billion over the next four years. The move comes as the

Pfizer to Buy Metsera in $7.3B Obesity Drug Push

by Jamie Spencer

Deal signals major move into booming weight loss market Pfizer announced Monday that it will acquire obesity drugmaker Metsera in a deal worth up to $7.3 billion, marking a significant move to

September 22, 2025

CEO Departure Marks Challenges for Novo Nordisk

by Jamie Spencer

Novo Nordisk CEO Lars Fruergaard Jørgensen will step down as part of an accelerated leadership transition, marking a significant shift in the company’s leadership. Former CEO Lars Rebien Sørensen, who currently serves

May 16, 2025

Eli Lilly’s Q4: Strong Drug Demand, But Sales Miss Target

by Jamie Spencer

Eli Lilly posted a mixed earnings report for the fourth quarter, with strong demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro driving revenue growth. However, sales slightly missed

February 6, 2025

Suggestions

Eli Lilly

Trump Threatens 250% Tariffs on Drug Imports

Wall Street Declines Amid Tariff Uncertainty

Johnson & Johnson Boosts U.S. Investments to $55B

Pfizer to Buy Metsera in $7.3B Obesity Drug Push

CEO Departure Marks Challenges for Novo Nordisk

Eli Lilly’s Q4: Strong Drug Demand, But Sales Miss Target